Affidea has acquired NU-MED Group from Enterprise Investors, enhancing its oncology service capabilities in Poland.
Target Information
NU-MED Group, a reputable healthcare provider based in Poland, specializes in comprehensive oncological treatments, including radiotherapy, brachytherapy, and chemotherapy. With over 17 years of experience in the healthcare sector, NU-MED operates four specialized medical facilities dedicated to diagnosing and treating cancer patients. This acquisition significantly enhances Affidea's service offerings in Poland, allowing it to provide an integrated range of cancer care services.
Industry Overview in Poland
The healthcare industry in Poland has been growing steadily, driven by increasing demand for quality medical services and technological advancements. The Polish healthcare system combines both public and private sectors, with ongoing reforms aimed at improving patient outcomes and expanding access to healthcare services.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Recent statistics indicate a surge in investment in healthcare facilities and innovation, particularly in specialized services like oncology, which remains a critical focus area
Similar Deals
Polmed S.A. → Kliniki Neuroradiochirurgii
2024
Affidea
invested in
NU-MED Group
in 2024
in a Other deal